• Explore /
  • Poster
  • / Efficacy of sequential perioperative FOLFIRNOX plus gemcitabine nab-paclitaxel for resected pancreatic and periampullary cancers.

Efficacy of sequential perioperative FOLFIRNOX plus gemcitabine nab-paclitaxel for resected pancreatic and periampullary cancers.

Abstract Video & Slides Poster

Authors

null

Putao Cen

The University of Texas Health Science Center at Houston (UTHealth Houston) McGovern Medical School, Houston, TX;

Putao Cen , Kok Hoe Chan , Curtis Jackson Wray , Nirav Thosani , John Bynon , Julie Haewon Rowe

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Pancreatic Cancer,Hepatobiliary Cancer,Neuroendocrine/Carcinoid,Small Bowel Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 41, 2023 (suppl 4; abstr 724)

DOI

10.1200/JCO.2023.41.4_suppl.724

Abstract #

724

Poster Bd #

L11

Abstract Disclosures

Similar Posters

First Author: Taro Shibuki

First Author: Ying Wang

First Author: Hiroyuki Asama

First Author: Vincent Chung